Literature DB >> 15641936

Low-T3 syndrome and signal-averaged ECG in haemodialysed patients.

A J Jaroszyński1, A Głowniak, B Chrapko, T Sodolski, T Małecka, T Widomska-Czekajska, A Ksiazek.   

Abstract

The study was designed to evaluate the potential link between low-T3 syndrome and signal-averaged ECG parameters (SAECG) in a group of hemodialyzed patients (HD-pts). 52 selected HD-pts (without relevant thyroid and cardiac diseases) were included. SAECGs were performed postdialysis together with evaluating free triiodothyronine (fT3), free thyroxine (fT4), reverse triiodothyronine (rT3), thyroid stimulating hormone levels and echocardiography. For each SAECG, QRS duration (QRSd), root-mean-square voltage of the terminal 40 ms of the QRS (RMS40), and low-amplitude signal duration (LAS40) were measured. Abnormal SAECGs were found in 30.8 % of HD-pt. HD-pts with decreased fT3 and increased rT3 values (low-T3 positive) revealed higher QRSd and LAS40 values in comparison with low-T3 negative HD-pts (p = 0.019, p < 0.001 respectively). Low-T3 positive HD-pts had lower RMS40 values than low-T3 negative patients (p < 0.001). The Pearson test showed significant correlations between QRSd and fT3 (r = -0.592, p < 0.001); QRSd and rT3 (r = 0.562, p < 0.001); RMS40 and fT3 (r = 0.432, p = 0.009); RMS40 and rT3 (r = -0.325, p = 0.025). On multivariate analysis, both fT3 and rT3 levels were found to be independent predictors of QRSd and RMS40 values. Our study showed that decreased fT3 and increased rT3 concentrations due to low-T3 syndrome influence SAECG parameters in HD-pt.

Entities:  

Mesh:

Year:  2005        PMID: 15641936

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  6 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  Low-T3 Syndrome in Peritoneal Dialysis: Metabolic Adaptation, Marker of Illness, or Mortality Mediator?

Authors:  Connie M Rhee
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-15       Impact factor: 8.237

3.  Low Triiodothyronine Syndrome and Long-Term Cardiovascular Outcome in Incident Peritoneal Dialysis Patients.

Authors:  Tae Ik Chang; Joo Young Nam; Sug Kyun Shin; Ea Wha Kang
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-15       Impact factor: 8.237

4.  Thyroid Functional Disease and Mortality in a National Peritoneal Dialysis Cohort.

Authors:  Connie M Rhee; Vanessa A Ravel; Elani Streja; Rajnish Mehrotra; Steven Kim; Jiaxi Wang; Danh V Nguyen; Csaba P Kovesdy; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  J Clin Endocrinol Metab       Date:  2016-08-15       Impact factor: 5.958

Review 5.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

Review 6.  The interaction between thyroid and kidney disease: an overview of the evidence.

Authors:  Connie M Rhee
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-10       Impact factor: 3.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.